According to Biolife Solutions 's latest financial reports the company's current earnings (TTM) are -$57.54 M. an increase over its 2022 earnings that were of -$0.11 B.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 | -$57.54 M | -45.98% |
2022 | -$0.11 B | 238.98% |
2021 | -$31.42 M | 211.88% |
2020 | -$10.08 M | -45.29% |
2019 | -$18.42 M | -663.11% |
2018 | $3.27 M | -240.64% |
2017 | -$2.33 M | -70.73% |
2016 | -$7.95 M | 57.92% |
2015 | -$5.04 M | 61.04% |
2014 | -$3.13 M | 813.46% |
2013 | -$0.35 M | -63.08% |
2012 | -$0.93 M | -27.96% |
2011 | -$1.29 M | |
2008 | -$2.47 M | -9.21% |
2007 | -$2.72 M | 81.58% |
2006 | -$1.5 M | |
2004 | -$0.66 M | -58.4% |
2003 | -$1.59 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Celanese CE | $1.18 B | -2,156.25% | ๐บ๐ธ USA |
Enanta Pharmaceuticals
ENTA | -$0.13 B | 124.66% | ๐บ๐ธ USA |
Amyris AMRS | -$0.6 B | 940.37% | ๐บ๐ธ USA |